Accept Refuse

EUR-Lex Access to European Union law

This document is an excerpt from the EUR-Lex website

Document 32006D0068

2006/68/EC: Commission Decision of 13 January 2006 authorising the placing on the market of foods and food ingredients derived from genetically modified maize line MON 863 as novel foods or novel food ingredients under Regulation (EC) No 258/97 of the European Parliament and of the Council (notified under document number C(2005) 5939)

OJ L 34, 7.2.2006, p. 26–28 (ES, CS, DA, DE, ET, EL, EN, FR, IT, LV, LT, HU, NL, PL, PT, SK, SL, FI, SV)
OJ L 118M , 8.5.2007, p. 125–127 (MT)

ELI: http://data.europa.eu/eli/dec/2006/68(1)/oj

7.2.2006   

EN

Official Journal of the European Union

L 34/26


COMMISSION DECISION

of 13 January 2006

authorising the placing on the market of foods and food ingredients derived from genetically modified maize line MON 863 as novel foods or novel food ingredients under Regulation (EC) No 258/97 of the European Parliament and of the Council

(notified under document number C(2005) 5939)

(Only the French and Dutch texts are authentic)

(2006/68/EC)

THE COMMISSION OF THE EUROPEAN COMMUNITIES,

Having regard to the Treaty establishing the European Community,

Having regard to Regulation (EC) No 258/97 of the European Parliament and of the Council of 27 January 1997 concerning novel foods and novel food ingredients (1), and in particular Article 7 thereof,

Whereas:

(1)

On 15 July 2002, Monsanto submitted to the competent authorities of Germany a request, in accordance with Article 4 of the Regulation, for placing on the market foods and food ingredients derived from genetically modified maize line MON 863 (hereinafter referred to as MON 863 maize) as novel foods or novel food ingredients, in accordance with Regulation (EC) No 258/97.

(2)

In its initial assessment report of 8 April 2003, Germany’s competent food assessment body came to the conclusion that an additional assessment was required because of the presence of an antibiotic resistance marker gene (nptII) used in the product concerned.

(3)

The Commission forwarded the initial assessment report to all Member States on 3 June 2003 with additional comments raised by the Member States.

(4)

On 9 December 2003 the Commission requested a scientific opinion from the European Food Safety Authority (EFSA) in accordance with Article 11 of the Regulation. On 2 April 2004 the EFSA delivered its opinion that from the point of view of consumer health, MON 863 maize and derived products are as safe as grain and derived products from conventional maize lines (2). In delivering its opinion the EFSA addressed all specific questions and concerns raised by the Member States.

(5)

Article 46(1) of Regulation (EC) No 1829/2003 of the European Parliament and of the Council of 22 September 2003 on genetically modified food and feed (3) provides that requests submitted under Article 4 of Regulation (EC) No 258/97 before the date of application of this Regulation shall be processed under the provisions of Regulation (EC) No 258/97, notwithstanding Article 38 of Regulation (EC) No 1829/2003, in cases where the additional assessment report required in accordance with Article 6(3) or 6(4) of Regulation (EC) No 258/97 has been transmitted to the Commission before the date of application of Regulation (EC) No 1829/2003.

(6)

The Joint Research Centre of the European Commission (JRC), in collaboration with the European Network of GMO Laboratories (ENGL), has validated a method for detection of MON 863 maize. The JRC has carried out a full validation study (ring-trial) following internationally accepted guidelines to test the performance of a quantitative event-specific method to detect and quantify the MON 863 transformation event in maize. The materials needed in the study had been provided by Monsanto. The JRC has considered that the method performance was appropriate for its purpose, taken into account the performance criteria proposed by the ENGL for methods submitted for regulatory compliance as well as the current scientific understanding about satisfactory method performance. Both the method and the results of the validation have been made publicly available.

(7)

Reference material for MON 863 maize has been produced by the JRC.

(8)

Food and food ingredients from MON 863 maize should be labelled in accordance with the provisions of Regulation (EC) No 1829/2003 and should be subject to the traceability requirements laid down in Regulation (EC) No 1830/2003 of the European Parliament and of the Council of 22 September 2003 concerning the traceability and labelling of genetically modified organisms and the traceability of food and feed products produced from genetically modified organisms and amending Directive 2001/18/EC (4).

(9)

In accordance with Commission Regulation (EC) No 65/2004 (5), a unique identifier has been assigned to the product for the purposes of Regulation (EC) No 1830/2003.

(10)

Information, contained in the Annex, on the identification of foods and food ingredients derived from MON 863 maize, including the validated detection method and the reference material, should be retrievable from the Register referred to in Article 28 of Regulation (EC) No 1829/2003.

(11)

On the basis of the information available, it is established that MON 863 maize complies with criteria laid down in Regulation (EC) No 258/97.

(12)

The Standing Committee on the Food Chain and Animal Health has not given an opinion; the Commission has therefore submitted a proposal to the Council on 26 July 2005 in accordance with Article 5(4) of the Council Decision 1999/468/EC (6), the Council being required to act within three months.

(13)

However, the Council has not acted within the required time limit; a Decision should now be adopted by the Commission,

HAS ADOPTED THIS DECISION:

Article 1

Foods and food ingredients derived from genetically modified maize line MON 863 (hereinafter referred to as the products), as designated and specified in the Annex, may be placed on the Community market as novel foods or novel food ingredients.

Article 2

The products shall be labelled as ‘genetically modified maize’ or ‘produced from genetically modified maize’ in accordance with the labelling requirements laid down in Article 13 of Regulation (EC) No 1829/2003.

Article 3

The products and the information included in the Annex shall be entered in the Community Register of genetically modified food and feed.

Article 4

This Decision is addressed to Monsanto Europe SA, Belgium, representing Monsanto Company, USA. It shall be valid for a period of 10 years.

Done at Brussels, 13 January 2006.

For the Commission

Markos KYPRIANOU

Member of the Commission


(1)  OJ L 43, 14.2.1997, p. 1. Regulation as last amended by Regulation (EC) No 1882/2003 (OJ L 284, 31.10.2003, p. 1).

(2)  EFSA Journal (2004) 50, 1-25; http://www.efsa.eu.int/science/gmo/gmo_opinions/383/opinion_gmo_07_en1.pdf

(3)  OJ L 268, 18.10.2003, p. 1.

(4)  OJ L 268, 18.10.2003, p. 24.

(5)  OJ L 10, 16.1.2004, p. 5.

(6)  OJ L 184, 17.7.1999, p. 23.


ANNEX

INFORMATION TO BE ENTERED IN THE COMMUNITY REGISTER OF GENETICALLY MODIFIED FOOD AND FEED

1.   Applicant and authorisation holder:

Name

:

Monsanto Europe SA

Address

:

Avenue de Tervuren 270-272, B-1150 Brussels, Belgium

On behalf of Monsanto Company, 800 N. Lindbergh Boulevard St. Louis, Missouri 63167, USA.

2.   Designation and specification of the products: Foods and food ingredients derived from genetically modified maize (Zea maize L.) line MON 863 with increased protection to insects and from all its crosses with traditionally bred maize lines. MON 863 maize contains two cassettes:

A modified cry3Bb1 gene derived from Bacillus thuringiensis subsp. kumamotoensis, which confers resistance to the corn rootworm Diabrotica spp., under the regulation of the 4AS1 promoter derived from Cauliflower Mosaic Virus, the wtCAB translation enhancer from wheat (Triticum aestivum), the transcription enhancer ract1 intron from the actin 1 gene of rice (Oryza sativa) and terminator sequences tahsp 17 3’ from wheat;

The nptII gene from E. coli, which confers resistance to aminoglycosides comprising kanamycin and neomycin, under the regulation of the 35S Cauliflower Mosaic Virus promoter, and the NOS 3’ terminator sequences from Agrobacterium tumefaciens as well as the non-functional, truncated ble gene from E. coli.

3.   Labelling: ‘Genetically modified maize’ or ‘produced from genetically modified maize’.

4.   Method for detection:

Event-specific real-time quantitative PCR based method for genetically modified maize line MON 863.

Validated by the Joint Research Centre (JRC) of the European Commission, in collaboration with the European Network of GMO Laboratories (ENGL), published at http://gmo-crl.jrc.it/statusofdoss.htm

Reference material: IRMM-416 produced by the Joint Research Centre (JRC) of the European Commission.

5.   Unique identifier: MON-ØØ863-5

6.   Information required under Annex II to the Cartagena Protocol: Not applicable.

7.   Conditions or restrictions for the placing on the market of the product: Not applicable.

8.   Post market monitoring requirements: Not applicable.


Top